col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Physiological Society: AJP Lung Cellular and Molecular Physiology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―07 Erythrocytes Identify Complement Activation in Patients with COVID-19 LK Metthew Lam, John Patrick Reilly, Ann H Rux, Sophia Murphy, Leticia Kuri-Cervantes, Ariel Weisman, et al. (+9)
2 [GO] 2021―Jun―22 The SARS-CoV-2 Spike Protein Subunit 1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells Ruben Colunga Biancatelli, Pavel Solopov, Elizabeth R Sharlow, John S Lazo, Paul Ellis Marik, John D Catravas
3 [GO] 2021―Jun―22 The significance of a lack of rhinorrhea in severe coronavirus 19 lung disease Michael Eisenhut
4 [GO] 2021―May―19 A Pilot Study to Assess the Circulating Renin-Angiotensin-System in COVID-19 Acute Respiratory Failure D. Clark Files, Kevin W. Gibbs, Christopher L. Schaich, Sean P. Collins, TanYa M. Gwathmey, Jonathan Dale Casey, et al. (+2)
5 [GO] 2021―May―12 The Oxygen Dissociation Curve of Blood in COVID-19 Dieter Böning, Wolfgang M. Kuebler, Wilhelm Bloch
6 [GO] 2021―May―05 The effect of estrogen in coronavirus disease 2019 (COVID-19) Qing Ma, Zhuo-wen Hao, Yan-feng Wang
7 [GO] 2021―Apr―06 In Silico investigation of the viroporin E as a vaccine target against SARS-CoV-2 Erasmia Rouka, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis
8 [GO] 2021―Mar―24 Implications of pre-existing asthma on COVID-19 pathogenesis Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
9 [GO] 2021―Mar―09 Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19 Vitalii Kryvenko, István Vadász
10 [GO] 2021―Feb―09 Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures Desiree Schütz, Carina Conzelmann, Giorgio Fois, Rüdiger Groß, Tatjana Weil, Lukas Wettstein, et al. (+6)
11 [GO] 2021―Jan―12 SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport Reem Abdel Hameid, Estelle Cormet-Boyaka, Wolfgang M. Kuebler, Mohammed Uddin, Bakhrom K Berdiev
12 [GO] 2021―Jan―06 Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19 Anthony V. Incognito, Philip J. Millar, W. Glen Pyle
13 [GO] 2021―Jan―06 Kinins and Chymase: The Forgotten Components of the Renin angiotensin system and their implications in COVID-19 Disease Zaid Abassi, Karl Skorecki, Dalit Ben Hamo-Giladi, Etty Kruzel-Davila, Samuel N Heyman
14 [GO] 2020―Dec―23 Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis? Lindsay T McDonald
15 [GO] 2020―Dec―02 Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Ariana Centa, Aline S. Fonseca, Solange G. da Silva Ferreira, Marina Luise V. Azevedo, Caroline B. Vaz de Paula, Seigo Nagashima, et al. (+5)
16 [GO] 2020―Nov―25 Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19 Faeq Husain-Syed, István Vadász, Jochen Wilhelm, Hans-Dieter Walmrath, Werner Seeger, Horst-Walter Birk, et al. (+19)
17 [GO] 2020―Nov―25 Angiotensin-Converting Enzyme 2 and COVID-19: Patients, Comorbidities, and Therapies Girish Pathangey, Priyal Praful Fadadu, Alexandra Raye Hospodar, Amr Abbas
18 [GO] 2020―Nov―11 Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections Mathew Suji Eapen, Wenying Lu, Tillie-Louise Hackett, Gurpreet K Singhera, Isobel E. Thompson, Kielan Darcy McAlinden, et al. (+6)
19 [GO] 2020―Nov―04 High-dimensional single-cell analysis reveals the immune characteristics of COVID-19 Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, et al. (+6)
20 [GO] 2020―Oct―28 Angiotensin-converting enzyme 2 (ACE2) expression in COPD and IPF fibroblasts- the forgotten cell in COVID-19 Noof Aloufi, Hussein Traboulsi, Jun Ding, Gregory J Fonseca, Parameswaran Nair, Steven K. Huang, et al. (+3)
21 [GO] 2020―Oct―14 Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19 Dusan Hanidziar, Simon C Robson
22 [GO] 2020―Sep―30 Pneumonia in the face of COVID-19 Martin Witzenrath, Wolfgang Michael Kuebler
23 [GO] 2020―Sep―30 VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC Leon Ferder, Virna Margarita Martín Giménez, Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, Walter Manucha
24 [GO] 2020―Sep―30 Sex steroids skew ACE2 expression in human airway: A contributing factor to sex differences in COVID-19? Rama Satyanarayana Raju Kalidhindi, Niyati A Borkar, Nilesh Sudhakar Ambhore, Christina M Pabelick, YS Prakash, Venkatachalem Sathish
25 [GO] 2020―Sep―30 "World Pneumonia Day During a Global Pneumonia Pandemic: 12 November 2020" Leith Greenslade
26 [GO] 2020―Sep―09 Human coronaviruses 229E and OC43 replicate and induce distinct anti-viral responses in differentiated primary human bronchial epithelial cells Su-Ling Loo, Peter A. B. Wark, Camille Esneau, Kristy S Nichol, Alan C-Y Hsu, Nathan W Bartlett
27 [GO] 2020―Sep―03 Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium Despoina Myti, Miša Gunjak, Francisco Casado, Solmaz Khaghani Raziabad, Claudio Nardiello, István Vadász, et al. (+4)
28 [GO] 2020―Aug―12 Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients Rodrigo Pacheco Silva-Aguiar, Diogo de Barros Peruchetti, Patricia Rieken Macedo Rocco, Alvin H Schmaier, Patricia Machado Rodrigues Silva, Marco Aurélio Martins, et al. (+3)
29 [GO] 2020―Aug―05 The potential role of the Carotid Body in COVID-19 Andrea Porzionato, Aron Emmi, Elena Stocco, Silvia Barbon, Rafael Boscolo-Berto, Veronica Macchi, Raffaele De Caro
30 [GO] 2020―Aug―05 SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs Rafal Bartoszewski, Michal Dabrowski, Bogdan Jakiela, Sadis Matalon, Kevin S. Harrod, Marek Sanak, James F. Collawn
31 [GO] 2020―Jul―22 Is there an association between the level of ambient air pollution and COVID-19 Baoming Wang, Hui Chen, Yik Lung Chan, Brian G. Oliver
32 [GO] 2020―Jul―15 SARS-CoV-2 (COVID-19) and Cystic Fibrosis Bruce A Stanton, Thomas H Hampton, Alix Ashare
33 [GO] 2020―Jul―08 DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Francesco Spannella
34 [GO] 2020―Jun―17 NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19 Francois Potus, Vicky Mai, Marius Lebret, Simon Malenfant, Emilie Breton-Gagnon, Annie C Lajoie, et al. (+3)
35 [GO] 2020―Jun―17 Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients Krishna Sriram, Paul A. Insel
36 [GO] 2020―Jun―17 Potential role for nitazoxanide in treating SARS-CoV-2 infection Paulo Ricardo Martins-Filho, José Antônio Barreto-Alves, Ricardo Fakhouri
37 [GO] 2020―Jun―10 Consideration of Pannexin 1 channels in COVID-19 pathology and treatment Leigh Anne Swayne, Scott R Johnstone, Chen Seng Ng, Juan C Sanchez-Arias, Miranda E Good, Silvia Penuela, et al. (+5)
38 [GO] 2020―Jun―10 Is targeting Akt a viable option to treat advanced-stage COVID-19 patients? Payaningal R Somanath
39 [GO] 2020―Jun―10 Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities. Joseph Alan Hippensteel, Wells B LaRiviere, James F Colbert, Christophe J Langouët-Astrié, Eric P. Schmidt
40 [GO] 2020―Jun―04 Thoughts on the alveolar phase of COVID-19 Robert J. Mason
41 [GO] 2020―Jun―03 Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Krithika Lingappan, Harry Karmouty-Quintana, Jonathan Davies, Bindu Akkanti, Matthew T Harting
42 [GO] 2020―May―28 P-selectin blockade in COVID-19-related ARDS Tommaso Neri, Dario Nieri, Alessandro Celi
43 [GO] 2020―May―20 Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells Kimberly E Stelzig, Fabrizio Canepa-Escaro, Marta Schiliro, Sergejs Berdnikovs, Y S Prakash, Sergio E Chiarella
44 [GO] 2020―May―13 Treatment of COVID-19 exacerbated asthma: should systemic corticosteroids be used? Kartik Kumar, Timothy SC Hinks, Aran Singanayagam
45 [GO] 2020―May―13 Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach Wolfgang Michael Kuebler, Sven-Eric Jordt, Wolfgang B. Liedtke
46 [GO] 2020―May―04 Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 Thomas Walther, Wolfgang M. Kuebler
47 [GO] 2020―May―04 Rigor before speculation in COVID-19 therapy Paul A. Welling, Daniel Batlle, James Brian Byrd, Louise M. Burrell, Andrew M. South, Matthew A. Sparks
48 [GO] 2020―May―04 Reply to Letter to the Editor: “Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 Zaid A. Abassi, Karl Skorecki, Samuel N. Heyman, Safa Kinaneh, Zaher Armaly
49 [GO] 2020―Apr―08 Call for Papers: The pathophysiology of COVID-19 and SARS-CoV-2 infection Rory E. Morty, John Ziebuhr
50 [GO] 2020―Apr―01 COVID-19 - is the ACE2 just a foe? Hrvoje Jakovac
51 [GO] 2020―Mar―24 Covid-19 infection and mortality - A physiologist's perspective enlightening clinical features and plausible interventional strategies Zaid A. Abassi, Karl Skorecki, Samuel Noam Heyman, Safa Kinaneh, Zaher Armaly


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec